Teva Pharmaceutical Industries (TEVA) Cash & Equivalents Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 36.44 Bn | 32.71 Bn | 1.97 Bn | 120.45% |
| 2 | Zoetis | 33.18 Bn | 31.24 Bn | 1.62 Bn | 12.78% |
| 3 | United Therapeutics | 23.36 Bn | 21.20 Bn | 648.10 Mn | -32.64% |
| 4 | Neurocrine Biosciences | 15.90 Bn | 14.58 Bn | 800.70 Mn | 37.30% |
| 5 | Aurora Cannabis | 15.07 Bn | 14.99 Bn | 21.72 Mn | -50.92% |
| 6 | Elanco Animal Health | 12.06 Bn | 11.63 Bn | 785.00 Mn | -12.11% |
| 7 | Hims & Hers Health | 8.09 Bn | 7.34 Bn | 396.79 Mn | -18.80% |
| 8 | Alkermes | 7.47 Bn | 6.96 Bn | -116.06 Mn | -12.07% |
| 9 | Lantheus Holdings | 6.69 Bn | 6.19 Bn | 230.92 Mn | -46.88% |
| 10 | Liquidia | 6.26 Bn | 6.03 Bn | 121.79 Mn | 31.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.45% |
| Dec 31, 2025 | 7.76% |
| Sep 30, 2025 | -33.62% |
| Jun 30, 2025 | -4.30% |
| Mar 31, 2025 | -43.26% |
| Dec 31, 2024 | 2.29% |
| Sep 30, 2024 | 47.58% |
| Jun 30, 2024 | -15.40% |
| Mar 31, 2024 | 39.57% |
| Dec 31, 2023 | 15.17% |
| Sep 30, 2023 | 1.08% |
| Jun 30, 2023 | 29.69% |
| Mar 31, 2023 | -1.47% |
| Dec 31, 2022 | 29.38% |
| Sep 30, 2022 | 8.80% |
| Jun 30, 2022 | -15.52% |
| Mar 31, 2022 | 24.78% |
| Dec 31, 2021 | -0.55% |
| Sep 30, 2021 | 11.93% |
| Jun 30, 2021 | 1.42% |